BRIAN NYBERG: Open Payments
NPI 1689968844 · CEDAR CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$827 in 35 payments from 15 companies in 2025. Trend: 2023 $260 · 2024 $1,561 · 2025 $827
Food & beverage: $827
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 5 | $218 |
| ABBVIE INC. | 7 | $136 |
| E.R. Squibb & Sons, L.L.C. | 4 | $82 |
| Alkermes, Inc. | 4 | $74 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Lundbeck LLC | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Indivior Inc. | 1 | $28 |
Products named: SPRAVATO, VRAYLAR, COBENFY, ARISTADA, REXULTI, INVEGA SUSTENNA, CAPLYTA, Auvelity.
Industry payments across UT — which companies pay providers there.
